Haleon PLC (HLN)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

358.90p

Buy

359.10p

arrow-down-3.10p (-0.86%)

Prices updated at 12 Dec 2025, 16:47 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
-
CEO
Mr. Brian James McNamara
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
24,622
Head office
The Heights
Weybridge
United Kingdom
KT13 0NY
mobile
+44 1932959500
letter
investor-relations@haleon.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Manvinder Singh Banga
Senior Independent Director
-
Mr. Alan James Stewart
Independent Director
-
Ms. Blathnaid Bergin
Independent Director
-
Ms. Marie Anne Aymerich
Independent Director
-
Ms. Asmita Dubey
Independent Director
-
Ms. Dawn Allen
Director and Chief Financial Officer
-
Mr. Brian James McNamara
Chief Executive Officer and Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc274,068,831
Principal Global Investors LLC233,066,636
Wellington Management Company LLP223,893,141
Dodge & Cox204,631,604
Massachusetts Financial Services Company187,354,723

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
23 Sep 2025D
23 Sep 2025D
23 Sep 2025D
18 Sep 2025D
30 Jun 2025Sale
30 Jun 2025Transfer in
30 Jun 2025Sale
30 Jun 2025Transfer in
12 Jun 2025D
10 Jun 2025D
10 Jun 2025D
10 Jun 2025D
05 Jun 2025D
16 May 2025Purchase
09 May 2025Purchase
02 May 2025Purchase
14 Mar 2025Sale
14 Mar 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.